First international conference on
1st International Conference
on the latest innovations and trends
in weight loss and weight management
Slimming Germany 2007
Slimming Germany Exhibition Space
Reserved only for ingredients with clinical studies
March 29-30, Palace Hotel, Berlin, Germany
Thursday, March 29, 2007
Dr Marvin Edeas, President of the French Society for Antioxidants, Paris, France
General overview on slimming ingredients
9:00 Overview of the European market of slimming ingredients: Innovations and
What are the innovations in the slimming field on the European markets?
What are the trends for the next years?
What about the Asian and US markets?
9:30 What are the different strategies to manage the body weight?
Targeting the lipid and carbohydrate metabolismIncreasing energy expenditure (physical activity, intake of energy expenditure boosters) Lowering energy intake (appetite suppressants) Pr Susanne Klaus, Deutsches Institut für Ernährungsforschung (DIFE) Potsdam-Rehbrücke, Nuthetal, Germany
What are the new molecular and cellular targets for the
development of the new generation of slimming ingredients?
10:00 Effects of Peroxisome Proliferator-Activated Receptors (PPARs) modulation on
Dr Markus Clemenz, Center for Cardiovascular Research (CCR), Charité-
Universitätsmedizin Berlin, Berlin, Germany
10:30 Break / Visit of the exhibition space
11:00 Role of mitochondria in weight management: how can antioxidants be useful in
Dr Marvin Edeas, President of The French Society for Antioxidants, Paris, France
11:30 Weight Management by using a special combination of antioxidants: presentation
of a clinical study with aLA and CoQ10.
Dr Ute Gola, Institute of Nutrition and Prevention, Berlin, Germany.
11:45 What’s new in the appetite suppressant field?
Dr Jason Halford, Kissileff Laboratory for the Study of Human Ingestive Behaviour, University of Liverpool, Liverpool, United Kingdom
12:15 Adipocytes: are there new targets to control their proliferation?
12:45 Lunch / Visit of the exhibition space
Nutrigenomics and Slimming Ingredients
14:00 Nutrigenomics and personalised nutrition in the control of Obesity. A preventive
role of leptin
Pr Andreu Palou and Dr Catalina Picó, Nutrition and Biotechnology, University of
the Balearic Islands, Palma de Mallorca, Spain
What are the current ingredients on the market with an
efficiency approved by clinical trials?
14:30 Thermogenic ingredients and weight loss: what’s new in 2007?
What are the latest scientific advances on thermogenic ingredients? Focus on spices (capsaicin), caffeine and catechines Results of a clinical study using a combination of bioactive food ingredients in obese subjects What are the perspectives of thermogenic ingredients in the weight loss and weight management field? Dr Anita Belza, Department of Human Nutrition, The Royal Veterinary and Agricultural University, Frederiksberg, Denmark
15:10 Potential role of inulin and oligofructose in satiety and weight management
Dr Liv Janvary, Palatinit GmbH, Mannheim, Germany
15:30 Overview of the Japanese market in the slimming field
Dr Mizuo Nasu, Ninapharm, Tokyo, Japan
16:00 Break / Visit of the exhibition space
16:30 Round table discussion: What are the ways to improve the scientific credibility of
slimming ingredients? In the presence of the Scientific Committee
17:00 End of the day
Friday March 30, 2007
What are the new concepts and innovative ideas on the
9:00 Strategies for modifying foods to increase satiety, and reduce subsequent intakes.
Dr Robert Welch, Northern Ireland Centre for Food and Health, University of Ulster, Coleraine, United Kingdom
9:30 Chloroplast membranes retard fat digestion and induce satiety
Pr Charlotte Erlanson-Albertsson, Department of Experimental Medicine, University of Lund, Lund, Sweden
10:00 Satiety induction by aromas: Novel insights in the possibilities to manage
weight through aromas in food products.
Dr Maurits Burgering and Dr Rianne Ruijschop NIZO Food research, Ede, The
10:30 Break / Visit of the exhibition space
11:00 New ingredients, technical innovations, new services on weight loss and weight
The Scientific Committee will select oral communications reserved for ingredients or
finished products with clinical trials / studies. These communications of 6 minutes are based on:
- originality of the compound or its mechanism of action
- new targets and new concepts
- new formulation and/or galenic
- new analysis methods
- new marketing and distribution concepts
- credibility of the clinical trials / studies
The satiety principle: a FabulessTM success in weight management products
DSM Food Specialties, Delft, The Netherlands
Influences of A dietary supplement in combination with an exercise and diet
regimen on adipocytokines and adiposity in women who are overweight
Imagenetix, SanDiego, USA
Peru Liana : Slimming anti-fat storage
ENGELHARD PCM Europe, BASF, France
Slim through appetite suppression: Pinno ThinTM the New breakthrough
Lipid Nutrition, Wormerveer, The Netherlands
12:00 Are slimming products really efficient? Point of view of a scientist
Dr Tatjana Pavicic, Clinic and Policlinic for Dermatology and Allergology, University of Munich, Germany
12:30 Lunch / Visit of the exhibition space
Food Industry and Slimming
14:00 Slimming Ingredients in functional food and drinks: what are the trends in 2007?
How is industry responding to the globesity challenge in terms of ingredients? What about consumer products and labelling schemes? What are the slimming ingredients used in drinks and beverages? Mr Tage Affertsholt, 3A Business Consulting, Aarhus, Denmark
Regulatory aspects of Slimming Ingredients
14:30 What are the latest developments in the slimming ingredients regulatory field?
Round Table Discussion
What are the perspectives in the design of
the Slimming Ingredients of tomorrow?
In the presence of the Scientific Committee
15:30 End of the Conference
Slimming Ingredients Germany 2007 Award:
Medicaid program to receive $8.7 million from huge national drug settlement GlaxoSmithKline settles drug marketing and pricing claims OLYMPIA – Attorney General Rob McKenna today announced Washington state’s share of the largest healthcare fraud settlement in U.S. history. “Thanks to a Medicaid-fraud fighting partnership between the states and the federal government, Washington
Fortbildungsreferat bei der Kreisärzteschaft Calw am 6. November 2002 Einleitung: In den letzten Jahren wurden 8 neue Antikonvulsiva mit unterschiedlichen Wirkmechanismen zu Behandlung von epileptischen Anfällen im Erwachsenenalter zugelassen. Die Indikation lautet in der Regel: Zusatz-Behandlung („add-on“) von komplex-fokalen Anfällen, die schwierig einzustellen sind. Wenige Medika